Home > Resources > Whitepapers > AXIOS™ Stent and Electrocautery Enhanced Delivery System

AXIOS™ Stent and Electrocautery Enhanced Delivery System

August 19, 2015

AXIOS™ Stent and Delivery System Indications for Use: The AXIOS Stent and Delivery System is indicated for use to facilitate transenteric endoscopic drainage of symptomatic pancreatic pseudocysts ≥6cm in size, with ≥ 70% fluid content that are adherent to the gastric or bowel wall. Once placed, the AXIOS Stent functions as an access port allowing passage of standard and therapeutic endoscopes to facilitate debridement, irrigation and cystoscopy. The stent is intended for implantation up to 60 days and should be removed upon confirmation of pseudocyst resolution.

Spotlight

Integrated Medical Services (IMS)

Integrated Medical Services (IMS) is a physician-led organization united through its providers’ commitment to high-quality, innovative health care. The multi-specialty group has primary care and most specialties well represented throughout the Phoenix metropolitan area and many rural locations. IMS started in 2006, when several community physicians determined that they could provide better patient care and gain efficiency by practicing together rather than separately. From there, our group has grown to approximately 130 providers and 65 locations.

OTHER WHITEPAPERS

Inclusive Health Systems: Innovations towards HealthEquity in Africa

whitePaper | January 13, 2023

The COVID-19 pandemic and response measures presented many hardships to people living in Sub-Saharan Africa.

Improving and Strengthening Employer-Sponsored Insurance

whitePaper | October 22, 2022

Under the leadership of former Senate Majority Leaders Tom Daschle and Bill Frist, M.D., BPC’s Health Program develops bipartisan policy recommendations that will improve health care quality, lower costs, and enhance coverage.

Shielding Healthcare from Cyberthreats

whitePaper | November 14, 2019

The sheer magnitude of hacker attention isn’t the only concern for healthcare security professionals. The job of securing the healthcare technology ecosystem is made infinitely more complicated by several factors that are unique to healthcare.

Top Priorities for Health Leaders 2022-2023

whitePaper | August 4, 2022

There has never been a time in the history of the U.S. healthcare system in which the leaders of hospitals, medical groups, and health systems have faced a broader range of pressures of all kindspolicy,

Global Insights: IoT & The Future of Healthcare

whitePaper | February 13, 2023

This research report, commissioned by Schneider Electric, demonstrates how IoT-based, open, interoperable platforms enable hyper-efficient, people-centric, resilient, and sustainable healthcare facilities of the future.

Decentralised Clinical Trials In The Eu

whitePaper | March 23, 2023

DCTs can take a variety of forms depending on patients’ needs, study protocol, drug company preferences, or regulatory requirements. Trials may be remote and decentralised from start to finish with no physical contact between participants and investigators or they may rely on hybrid designs that incorporate only certain elements of decentralisatio

AXIOS™ Stent and Electrocautery Enhanced Delivery System